Search

Your search keyword '"Curto-Barredo L"' showing total 14 results
Start Over Author "Curto-Barredo L" Journal actas dermo-sifiliograficas
14 results on '"Curto-Barredo L"'

1. [Translated article] Drug Survival in Cyclosporine Treatment for Moderate to Severe Atopic Dermatitis: Analysis of the Spanish Atopic Dermatitis Registry (BIOBADATOP)

Author

Couselo-Rodríguez, C., primary, Batalla, A., additional, Carrascosa, J.M., additional, Chicharro, P., additional, González-Quesada, A., additional, de la Cueva, P., additional, Giménez-Arnau, A.M., additional, Gilaberte, Y., additional, Rodríguez-Serna, M., additional, Montero-Vilchez, T., additional, Ruiz-Villaverde, R., additional, Elosua-González, M., additional, Silvestre-Salvador, J.F., additional, Munera-Campos, M., additional, Sánchez-Pérez, J., additional, Carretero, G., additional, Mauleón-Fernández, C., additional, Curto-Barredo, L., additional, Ballano-Ruiz, A., additional, Botella-Estrada, R., additional, Arias-Santiago, S., additional, Navarro-Triviño, F.J., additional, Roustan-Gullón, G., additional, Betlloch, I., additional, del Alcázar, E., additional, Abalde-Pintos, M.T., additional, Suárez-Perez, J., additional, García-Doval, I., additional, Descalzo, M.Á., additional, and Flórez, Á., additional

Published
2024
Full Text
View/download PDF

2. Supervivencia de la ciclosporina en el tratamiento de la dermatitis atópica moderada-grave: Registro Español de Dermatitis Atópica (BIOBADATOP)

Author

Couselo-Rodríguez, C., primary, Batalla, A., additional, Carrascosa, J.M., additional, Chicharro, P., additional, González-Quesada, A., additional, de la Cueva, P., additional, Giménez-Arnau, A.M., additional, Gilaberte, Y., additional, Rodríguez-Serna, M., additional, Montero-Vilchez, T., additional, Ruiz-Villaverde, R., additional, Elosua-González, M., additional, Silvestre-Salvador, J.F., additional, Munera-Campos, M., additional, Sánchez-Pérez, J., additional, Carretero, G., additional, Mauleón-Fernández, C., additional, Curto-Barredo, L., additional, Ballano-Ruiz, A., additional, Botella-Estrada, R., additional, Arias-Santiago, S., additional, Navarro-Triviño, F.J., additional, Roustan-Gullón, G., additional, Betlloch, I., additional, del Alcázar, E., additional, Abalde-Pintos, M.T., additional, Suárez-Perez, J., additional, García-Doval, I., additional, Descalzo, M.Á., additional, and Flórez, Á., additional

Published
2024
Full Text
View/download PDF

3. BIOBADATOP: Registro Español de Dermatitis Atópica. Descripción y primeros resultados

Author

Munera-Campos, M., primary, Chicharro, P., additional, Gonzalez Quesada, A., additional, Florez Menendez, A., additional, de la Cueva Dovao, P., additional, Gimenez Arnau, AM., additional, Gilaberte Calzada, Y., additional, Rodríguez Serna, M., additional, Montero, T., additional, Silvestre Salvador, JF., additional, Elosua González, M., additional, del Alcazar, E., additional, Santamaría, C., additional, Sánchez-Pérez, J., additional, Carretero Hernández, G., additional, Batalla Cebey, A., additional, Jin Suh Oh, H., additional, Mauleón Fernández, C., additional, Curto Barredo, L., additional, Bertolín, M., additional, Navarro Bielsa, A., additional, Ballano Ruiz, A., additional, Botella Estrada, R., additional, Arias Santiago, S., additional, Betlloch, I., additional, Roustan Gullón, G., additional, Rosell Díaz, A., additional, Descalzo, MÁ., additional, García-Doval, I., additional, and Carrascosa, JM., additional

Published
2023
Full Text
View/download PDF

4. Algoritmo de tratamiento con omalizumab en urticaria crónica espontánea

Author

Spertino, J., primary, Curto Barredo, L., additional, Rozas Muñoz, E., additional, Figueras Nart, I., additional, Gimenez Arnau, A., additional, Serra Baldrich, E., additional, Bonfill-Ortí, M., additional, Expósito-Serrano, V., additional, Guilabert, A., additional, Melé Ninot, G., additional, Villar Buil, M., additional, Garcias Ladaria, J., additional, García Navarro, X., additional, Vilavella, M., additional, Bielsa Marsol, I., additional, Aparicio Ortiz, G., additional, Baliu Piqué, C., additional, Álvarez Abella, A., additional, Lamas Domenech, N., additional, Mascaró, J.M., additional, Gómez, S., additional, Torné Gutiérrez, J.I., additional, and Vicente Villa, A., additional

Published
2018
Full Text
View/download PDF

8. Algorithm for Treatment of Chronic Spontaneous Urticaria with Omalizumab

Author

Spertino, J., Curto Barredo, L., Rozas Muñoz, E., Figueras Nart, I., Serra Baldrich, E., Bonfill-Ortí, M., Expósito-Serrano, V., Guilabert, A., Melé Ninot, G., Villar Buil, M., Garcias Ladaria, J., García Navarro, X., Vilavella, M., Bielsa Marsol, I., Aparicio Ortiz, G., Baliu Piqué, C., Álvarez Abella, A., Lamas Domenech, N., Mascaró, J.M., Gómez, S., Torné Gutiérrez, J.I., Vicente Villa, A., and Gimenez Arnau, A.

Abstract

Pivotal trials with omalizumab for treatment of chronic spontaneous urticaria (CSU) are generally run over 12 to 24weeks. However, in clinical practice, many patients need longer treatment. In this article, we present an algorithm for treatment with omalizumab.

Published
2018
Full Text
View/download PDF

10. [Translated article] BIOBADATOP Spanish Atopic Dermatitis Registry: Description and Early Findings

Author

Munera-Campos, M., Chicharro, P., Gonzalez Quesada, A., Flórez Menéndez, Á., de la Cueva Dobao, P., Gimenez Arnau, A.M., Gilaberte Calzada, Y., Rodríguez Serna, M., Montero-Vilchez, T., Silvestre, J.F., Elosua-González, M., del Alcázar, E., Santamaría, C., Sánchez-Pérez, J., Carretero Hernández, G., Batalla, A., Jin Suh Oh, H., Mauleón Fernández, C., Curto Barredo, L., Bertolín-Colilla, M., Navarro Bielsa, A., Ballano Ruiz, A., Botella Estrada, R., Arias Santiago, S., Betlloch, I., Roustan Gullón, G., Rosell Díaz, A., Descalzo, M.A., García-Doval, I., and Carrascosa, J.M.

Abstract

[Display omitted]

Published
2023
Full Text
View/download PDF

11. Cross-Cultural Adaptation of the Urticaria Control Test From German to Castilian Spanish

Author

García-Díez, I., Curto-Barredo, L., Weller, K., Pujol, R.M., Maurer, M., and Giménez-Arnau, A.M.

Abstract

The clinical concept of urticaria embraces a heterogeneous group of conditions classified according to their clinical course as acute (lasting less than 6 weeks) or chronic (lasting 6 weeks or more). Chronic urticaria may be either spontaneous or induced. Few tools are available for monitoring the various clinical forms of this disease or for evaluating its impact on quality of life. The recently developed Urticaria Control Test to evaluate disease control is available in German, the original language, and American English.

Published
2015
Full Text
View/download PDF

12. Adaptación transcultural del cuestionario Urticaria Control Testdel alemán al castellano

Author

García-Díez, I., Curto-Barredo, L., Weller, K., Pujol, R.M., Maurer, M., and Giménez-Arnau, A.M.

Abstract

Bajo el concepto de urticaria se incluye un grupo heterogéneo de entidades clasificadas según su evolución en urticaria aguda (duración inferior a 6 semanas) y urticaria crónica (duración igual o superior a 6 semanas). Las formas crónicas incluyen la urticaria crónica espontánea y las urticarias inducibles. Disponemos de un número limitado de herramientas para la monitorización de las distintas formas clínicas de urticaria y para la valoración de su impacto en la calidad de vida. Recientemente se ha creado el cuestionario Urticaria Control Testcomo herramienta para valorar el control de la urticaria, disponible tanto en alemán, el idioma original, como en inglés americano.

Published
2015
Full Text
View/download PDF

13. Update on the Treatment of Chronic Urticaria

Author

Curto-Barredo, L., Silvestre, J.F., and Giménez-Arnau, A.M.

Abstract

Chronic spontaneous urticaria, also known as chronic idiopathic urticaria or simply chronic urticaria, is a common disorder that has a prevalence in the general population that ranges between 0.5% and 1%. This condition negatively affects the patient's quality of life and has considerable impact on direct and indirect health-related costs. Chronic urticaria is difficult to manage. Nonsedating H1antihistamines are the first line of therapy, but fewer than 50% of patients experience relief at recommended dosages. Although guidelines call for increasing the dosage when response is inadequate, some patients still do not achieve adequate control of symptoms. New treatment alternatives, with proven efficacy under the standards of evidence-based medical practice, must therefore be developed.

Published
2014
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results